Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection

Mitchell, JL; Pollara, J; Dietze, K; Edwards, RW; Nohara, J; N'guessan, KF; Zemil, M; Buranapraditkun, S; Takata, H; Li, YF; Muir, R; Kroon, E; Pinyakorn, S; Jha, S; Manasnayakorn, S; Chottanapund, S; Thantiworasit, P; Prueksakaew, P; Ratnaratorn, N; Nuntapinit, B; Fox, L; Tovanabutra, S; Paquin-Proulx, D; Wieczorek, L; Polonis, VR; Maldarelli, F; Haddad, EK; Phanuphak, P; Sacdalan, CP; Rolland, M; Phanuphak, N; Ananworanich, J; Vasan, S; Ferrari, G; Trautmann, L

Trautmann, L (通讯作者),Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185Th Ave,1107D, Beaverton, OR 97006 USA.;Ferrari, G (通讯作者),Duke Univ, Med Ctr, Dept Surg, 915 S Lasalle St,Sorf Bldg,Room 208, Durham, NC 27710 USA.

JOURNAL OF CLINICAL INVESTIGATION, 2022; 132 (1):

Abstract

Early initiation of antiretroviral therapy (ART) in acute HIV infection (AHI) is effective at limiting seeding of the HIV viral reservoir, but little ......

Full Text Link